nemolizumab
Showing 1 - 9 of 9
Healthy Volunteers Trial in Tempe, Lincoln (Nemolizumab)
Completed
- Healthy Volunteers
- Nemolizumab
-
Tempe, Arizona
- +1 more
Dec 13, 2022
Systemic Sclerosis Trial in Tokyo (nemolizumab)
Recruiting
- Systemic Sclerosis
- nemolizumab
-
Tokyo, JapanThe University of Tokyo Hospital
May 11, 2022
Atopic Dermatitis Trial in Bulgaria, United States (Nemolizumab, CYP 450 Substrates)
Recruiting
- Atopic Dermatitis
- Nemolizumab
- CYP 450 Substrates
-
North Hollywood, California
- +6 more
Nov 29, 2022
Prurigo Nodularis Trial in Austria, United States (Nemolizumab, Placebo)
Recruiting
- Prurigo Nodularis
- Nemolizumab
- Placebo
-
Irvine, California
- +4 more
Aug 12, 2022
Moderate-to-severe Atopic Dermatitis Trial (Nemolizumab, CD14152 )
Withdrawn
- Moderate-to-severe Atopic Dermatitis
- Nemolizumab
- CD14152 placebo
- (no location specified)
Jan 6, 2022
Moderate-to-Severe Atopic Dermatitis Trial in Worldwide (Nemolizumab)
Recruiting
- Moderate-to-Severe Atopic Dermatitis
- Nemolizumab
-
Fountain Valley, California
- +30 more
Jul 20, 2022
Chronic Kidney Disease Associated Moderate to Severe Pruritus Trial in Worldwide (Nemolizumab, Placebo)
Recruiting
- Chronic Kidney Disease Associated Moderate to Severe Pruritus
- Nemolizumab
- Placebo
-
Hoover, Alabama
- +77 more
Dec 13, 2022
Moderate-to-Severe Atopic Dermatitis Trial in Worldwide (Placebo, Nemolizumab)
Active, not recruiting
- Moderate-to-Severe Atopic Dermatitis
- Placebo
- Nemolizumab
-
Little Rock, Arkansas
- +201 more
Aug 24, 2022
Atopic Dermatitis Trial in Worldwide (Nemolizumab, Placebo)
Completed
- Atopic Dermatitis
- Nemolizumab
- Placebo
-
Birmingham, Alabama
- +66 more
Oct 3, 2019